Patrick Lin - Aug 5, 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Aug 5, 2022
Transactions value $
-$8,420
Form type
4
Date filed
8/9/2022, 04:22 PM
Previous filing
Jul 5, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +7.6K +1.75% 441K Aug 5, 2022 Direct F1
transaction PCSA Common Stock Tax liability -$8.42K -2.66K -0.6% $3.17 438K Aug 5, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based shares.